Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.

Chapman, P B; Lester, T J; Casper, E S; Gabrilove, J L; Wong, G Y; Kempin, S J; Gold, P J; Welt, S; Warren, R S; Starnes, H F

Chapman, P B; Lester, T J; Casper, E S; Gabrilove, J L; Wong, G Y; Kempin, S J; Gold, P J; Welt, S; Warren, R S; Starnes, H F.

Affiliation

Chapman PB; Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

J Clin Oncol ; 5(12): 1942-51, 1987 Dec.

Article in En | MEDLINE | ID: mdl-3681377

Subject(s)

Neoplasms/therapy; Tumor Necrosis Factor-alpha/therapeutic use; Adult; Aged; Blood Cell Count; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Neoplasms/blood; Recombinant Proteins; Tumor Necrosis Factor-alpha/administration & dosage; Tumor Necrosis Factor-alpha/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tumor Necrosis Factor-alpha / Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1987 Type: Article

Search on Google

XML

PubMed Links